Literature DB >> 20844348

Opioid-induced hyperalgesia and tolerance.

Mary Hanna Bekhit1.   

Abstract

We have all encountered the following postanesthesia care unit dilemma a myriad of times. As the attending covering the postanesthesia care unit, the anesthesiologist will be confronted not infrequently with the following clinical scenario: "He needed 500 μg fentanyl in the operating room for a toe amputation and has received 20 mg morphine, and he's still complaining of severe pain…. Do you think he may need more morphine?" Opiates do prevail as first-line therapy for moderate to severe surgical and chronic pain states. However, their use may actually confound the clinical picture postoperatively, because opiate exposure counterintuitively may actually trigger exaggerated pain sensation. When assessing a patient experiencing exaggerated postoperative or chronic pain, several questions should come to mind. First, is this patient experiencing tolerance or hyperalgesia induced by opiate therapy? Second, does the management differ for the two etiologies? Third, what underlying mechanisms, both at the neuroanatomic and molecular/chemical levels, underlie the two processes? Fourth, how does the recent literature on opiate-induced hyperalgesia influence previously accepted views of pre-emptive analgesia? Fifth, what treatment modalities exist for opiate-induced hyperalgesia? Most importantly, sixth, how can opiate-induced hyperalgesia be prevented? In this literature review, we aim to address these questions and to hopefully change the current perception and management of perioperative and chronic pain states with opiates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20844348     DOI: 10.1097/MJT.0b013e3181ed83a0

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  30 in total

1.  Nerve injury-induced epigenetic silencing of opioid receptors controlled by DNMT3a in primary afferent neurons.

Authors:  Linlin Sun; Jian-Yuan Zhao; Xiyao Gu; Lingli Liang; Shaogen Wu; Kai Mo; Jian Feng; Weixiang Guo; Jun Zhang; Alex Bekker; Xinyu Zhao; Eric J Nestler; Yuan-Xiang Tao
Journal:  Pain       Date:  2017-06       Impact factor: 6.961

Review 2.  Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.

Authors:  Adeleke D Adewumi; Christine E Staatz; Samantha A Hollingworth; Jason P Connor; Rosa Alati
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

Review 3.  Anesthesia and analgesia in the NICU.

Authors:  R Whit Hall
Journal:  Clin Perinatol       Date:  2012-03       Impact factor: 3.430

4.  Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.

Authors:  Aswini Kumar Giri; Christopher R Apostol; Yue Wang; Brittany L Forte; Tally M Largent-Milnes; Peg Davis; David Rankin; Gabriella Molnar; Keith M Olson; Frank Porreca; Todd W Vanderah; Victor J Hruby
Journal:  J Med Chem       Date:  2015-10-30       Impact factor: 7.446

5.  Opioid receptor-triggered spinal mTORC1 activation contributes to morphine tolerance and hyperalgesia.

Authors:  Ji-Tian Xu; Jian-Yuan Zhao; Xiuli Zhao; Davinna Ligons; Vinod Tiwari; Fidelis E Atianjoh; Chun-Yi Lee; Lingli Liang; Weidong Zang; Dolores Njoku; Srinivasa N Raja; Myron Yaster; Yuan-Xiang Tao
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

6.  Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.

Authors:  Dioneia Araldi; Luiz F Ferrari; Jon D Levine
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

Review 7.  Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.

Authors:  Gordon A Barr; Anika McPhie-Lalmansingh; Jessica Perez; Michelle Riley
Journal:  ILAR J       Date:  2011

Review 8.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

9.  Morphine enhances IL-1β release through toll-like receptor 4-mediated endocytic pathway in microglia.

Authors:  Yongxin Liang; Haichen Chu; Yanan Jiang; Li Yuan
Journal:  Purinergic Signal       Date:  2016-08-09       Impact factor: 3.765

10.  Intrathecal rapamycin attenuates morphine-induced analgesic tolerance and hyperalgesia in rats with neuropathic pain.

Authors:  Ji-Tian Xu; Linlin Sun; Brianna Marie Lutz; Alex Bekker; Yuan-Xiang Tao
Journal:  Transl Perioper Pain Med       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.